Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the TRK kinase pathway

作者: K Thress , T MacIntyre , H Wang , ZY Liu , E Hoffmann

DOI:

关键词:

摘要:

参考文章(0)